What is the Aminologics Co., Ltd. stock price forecast?

Aminologics Co., Ltd. is currently trading at ₩1,221. View real-time AI analysis on Alpha Lenz.

What is Aminologics Co., Ltd. insider trading activity?

View the latest insider trading data for Aminologics Co., Ltd. on Alpha Lenz.

What is Aminologics Co., Ltd.'s P/E ratio?

Aminologics Co., Ltd.'s P/E ratio is 30.5.

Aminologics Co., Ltd.

KRX · 074430

₩1,221-5(-0.41%)Market closed

Ask about Aminologics Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Aminologics Co., Ltd. trades at a P/E of 30.5 (premium valuation) with modest ROE of 6.5%.”

Ask for details →

Company Overview

Aminologics Co., Ltd. is a biotechnology company focused on developing and manufacturing innovative healthcare solutions. The company's primary function is to provide advanced therapeutic products, particularly in the field of diagnostics and medical treatments. Aminologics plays a significant role in the healthcare sector, offering products that cater to various medical needs and advancements. The company's operations are integral to the biotechnology and pharmaceutical industries, contributing to research and product development processes. Through its innovative solutions, Aminologics Co., Ltd. aims to address critical health issues and improve patient care, thereby enhancing the overall quality of healthcare offerings in the market. Headquartered in South Korea, Aminologics is part of a global network of healthcare innovators driving progress in medical science and technology.

CEO오장석,오성석

Websitehttps://www.aminologics.co.kr

SectorCommon Stock

IndustryCommon Stock

Company Statistics

FY 2025

Profile

₩107,236,576,524Market Cap

₩22,020,233,500Revenue

87.83MShares Out

0Employees

Margins

44.78%Gross

24.82%EBITDA

16.32%Operating

15.96%Pre-Tax

15.99%Net

Valuation

30.45P/E

1.92P/B

4.87EV/Sales

17.75EV/EBITDA

42.98P/FCF

Growth (CAGR)

-6.96%Rev 3Yr

4.52%Rev 5Yr

-20.06%Op Inc 3Yr

6.82%Op Inc 5Yr

N/ANet Inc 3Yr

10.48%Net Inc 5Yr

Returns

5.00%ROA

6.54%ROE

6.38%ROIC

Financial Health

₩26,455,998,060Cash & Cash Equivalents

₩1,728,504,960Net Debt

50.34%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Aminologics Co., Ltd. trades at a P/E of 30.5 (premium valuation) with modest ROE of 6.5%.”

Ask for details →

Frequently Asked Questions

Aminologics Co., Ltd. (ticker: 074430) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $107.2B.

The current price is ₩1,221 with a P/E ratio of 30.45x and P/B of 1.92x.

ROE is 6.54% and operating margin is 16.32%. Annual revenue is $22.0B.